Then there is the clinical testing in Madrid. They had mentioned sharing results in the 2nd half of last year. If the guy from Woodley mentioned above is buying in at 10x maybe that is a sign that testing went well and results are forthcoming? I can't see him making this purchase if the results were looking bad?
"We look forward to reporting the results from this study which should be completed in the second half of the year.”
https://finance.yahoo.com/news/nanomix-initiates-clinical-study-elab-130000572.html
imho
mj
Recent NNMX News
- Form 8-K - Current report • Edgar (US Regulatory) • 11/24/2023 09:20:02 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM